Carl-Göran Ericsson

1.6k citations

22 papers · 1.3k indexed · h-index 18

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Cardiology and Cardiovascular Medicine top 5%
- Lipid metabolism and disorders

Papers in

Cardiology and Cardiovascular Medicine 13
- Acute Myocardial Infarction Research 5
- Lipid metabolism and disorders 3
- Cardiac electrophysiology and arrhythmias 3
Endocrinology, Diabetes and Metabolism 5
- Diabetes, Cardiovascular Risks, and Lipoproteins 4

Co-authors: Anders Hamsten Per Tornvall Angela Silveira Ann Samnegård Susanna Boquist Marie Bennermo Claes Held Ulf dé Fairé
Journals: Atherosclerosis (3 papers)Thrombosis and Haemostasis (3 papers)Journal of the American College of Cardiology (2 papers)Circulation (1 paper)Cardiology (1 paper)
Partner nations: Sweden United Kingdom Russia

In The Last Decade

Carl-Göran Ericsson

22 papers receiving 1.3k citations

Peers

Countries citing papers authored by Carl-Göran Ericsson

Since Specialization

Citations

This map shows the geographic impact of Carl-Göran Ericsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl-Göran Ericsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl-Göran Ericsson more than expected).

Fields of papers citing papers by Carl-Göran Ericsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl-Göran Ericsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl-Göran Ericsson. The network helps show where Carl-Göran Ericsson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carl-Göran Ericsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carl-Göran Ericsson Line = papers co-authored together Carl-Göran Ericsson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Genetic and Environmental Influences on the Plasma Interleukin-6 Concentration in Patients with a Recent Myocardial Infarction: A Case–Control Study Journal of Interferon & Cytokine Research ·Marie Bennermo, Margareta Nordin, Pia Lundman, Sofia Boqvist, Claes Held, Ann Samnegård, Carl-Göran Ericsson, Angela Silveira, Anders Hamsten, 钟淑薇, Per Tornvall	2010	34
2	Gender specific associations between matrix metalloproteinases and inflammatory markers in post myocardial infarction patients Atherosclerosis ·Ann Samnegård, Johannes Hulthe, Angela Silveira, Carl-Göran Ericsson, Anders Hamsten, Per Eriksson	2008	34
3	Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction Thrombosis and Haemostasis ·Per Eriksson, Carl-Göran Ericsson, Anders Hamsten, Angela Silveira, Maria Mannila	2006	30
4	A high-fat meal is accompanied by increased plasma interleukin-6 concentrations Nutrition Metabolism and Cardiovascular Diseases ·Pia Lundman, Susanna Boquist, Ann Samnegård, Marie Bennermo, Claes Held, Carl-Göran Ericsson, Angela Silveira, Anders Hamsten, Per Tornvall	2006	92
5	Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation Thrombosis and Haemostasis ·Claes Held, Carl-Göran Ericsson, Angela Silveira, Anders Hamsten, Per Tornvall, Marie Bennermo	2005	6
6	Human genetic evidence that OX40 is implicated in myocardial infarction Biochemical and Biophysical Research Communications ·Massimiliano Ria, Per Eriksson, Susanna Boquist, Carl-Göran Ericsson, Anders Hamsten, Jacob Lagercrantz	2005	34
7	Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction Thrombosis and Haemostasis ·Per Eriksson, Pia Lundman, Ann Samnegård, Susanna Boquist, Carl-Göran Ericsson, Per Tornvall, Anders Hamsten, Angela Silveira, Maria Mannila	2005	34
8	Plasma C-Reactive Protein and Lipoprotein Levels, and Progression of Coronary Artery Disease after Myocardial Infarction Treated with Thrombolysis Cardiology ·Per Tornvall, Anders Hamsten, Lars‐Olof Hansson, Amanda Baby, Carl-Göran Ericsson, Alane Pereira Alves, Krishnaja M Unnikrishnan, L. Bergstrand	2005	2
9	Prognostic value of plasma interleukin-6 concentrations and the −174 G > C and −572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis Atherosclerosis ·Marie Bennermo, Claes Held, Fiona Green, Alane Pereira Alves, Carl-Göran Ericsson, Lars‐Olof Hansson, Hugh Watkins, Anders Hamsten, Per Tornvall	2004	64
10	A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein Atherosclerosis ·Alexander Kovacs, Fiona Green, Lars‐Olof Hansson, Pia Lundman, Ann Samnegård, Susanna Boquist, Carl-Göran Ericsson, Hugh Watkins, Anders Hamsten, Per Tornvall	2004	106
11	Human Evidence That the Cystatin C Gene Is Implicated in Focal Progression of Coronary Artery Disease Arteriosclerosis Thrombosis and Vascular Biology ·Per Eriksson, Hiroyuki Deguchi, Ann Samnegård, Pia Lundman, Susanna Boquist, Per Tornvall, Carl-Göran Ericsson, L. Bergstrand, Lars‐Olof Hansson, Shu Ye, Anders Hamsten	2004	82
12	Genetic Predisposition of the Interleukin-6 Response to Inflammation: Implications for a Variety of Major Diseases? Clinical Chemistry ·Marie Bennermo, Claes Held, Sten Stemme, Carl-Göran Ericsson, Angela Silveira, Fiona Green, Per Tornvall	2004	166
13	Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment Journal of the American College of Cardiology ·Giacomo Ruotolo, Peter Båvenholm, Kerstin Brismar, Suad Efendić, Carl-Göran Ericsson, Ulf dé Fairé, Jan Nilsson, Anders Hamsten	2000	75
14	Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) Journal of the American College of Cardiology ·Giacomo Ruotolo, Carl-Göran Ericsson, Raeiati Damavandi Mayade, Fredrik Karpe, Lars Grip, Bertil Svane, Jan Nilsson, Ulf dé Fairé, Anders Hamsten	1998	134
15	Evidence for a role of tumor necrosis factor α in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease Metabolism ·Stefan Jovinge, Anders Hamsten, Sarahi Arias-Martínez, Anthony J. Proudler, Peter Båvenholm, Carl-Göran Ericsson, Ian F. Godsland, Ulf dé Fairé, Jan Nilsson	1998	142
16	Emotional distress before coronary bypass grafting limits the benefits of surgery American Heart Journal ·Aleksander Perski, Elehu Feleke, Gunilla Anderson, Bassem A. Samad, Hugo Westerlund, Carl-Göran Ericsson, Nina Rehnqvist	1998	66
17	Effect of Bezafibrate Treatment Over Five Years on Coronary Plaques Causing 20% to 50% Diameter Narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]) The American Journal of Cardiology ·Carl-Göran Ericsson, Jan Nilsson, Lars Grip, Bertil Svane, Anders Hamsten	1997	81
18	Retardation of Coronary Atherosclerosis: The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and Other Angiographic Trials Cardiovascular Drugs and Therapy ·Ulf dé Fairé, Carl-Göran Ericsson, Lars Grip, Jan Nilsson, Bertil Svane, Anders Hamsten	1997	26
19	Trends in Coronary Care Acta Medica Scandinavica ·Carl-Göran Ericsson, Bo Lindvall, Gunnar Olsson, Nina Rehnqvist, Fundació Cercle d'Economia, Göran Svensson, Leif Erhardt	1988	12
20	Comparative Investigation of the Antiarrhythmic Effect of Propafenone (Rytmonorm) and Lidocaine in Patients with Ventricular Arrhythmias during Acute Myocardial Infarction Acta Medica Scandinavica ·Nina Rehnqvist, Carl-Göran Ericsson, Sven V. Eriksson, Gunnar Olsson, Göran Svensson	1984	22

About Carl-Göran Ericsson

Carl-Göran Ericsson is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology, Immunology and Hematology, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (9 papers), Acute Myocardial Infarction Research (5 papers), Blood properties and coagulation (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Lipid metabolism and disorders (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (306 citations), Cardiology and Cardiovascular Medicine (374 citations), Immunology (260 citations), Epidemiology (408 citations) and Cancer Research (148 citations). Carl-Göran Ericsson has collaborated with scholars based in Sweden, United Kingdom and Russia. Frequent co-authors include Anders Hamsten, Per Tornvall, Angela Silveira, Ann Samnegård, Susanna Boquist, Marie Bennermo, Claes Held, Ulf dé Fairé, Fiona Green and Lars Grip. Their work appears in journals such as Atherosclerosis, Thrombosis and Haemostasis, Journal of the American College of Cardiology, Circulation and Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact